Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept study

INTRODUCTION: Chronic inflammatory demyelinating polyneuropathy (CIDP) is one of the most common immune neuropathies leading to severe impairments in daily life. Current treatment options include intravenous immunoglobulins (IVIG), which are administered at intervals of 4–12 weeks. Determination of...

Descripción completa

Detalles Bibliográficos
Autores principales: Masanneck, Lars, Voth, Jan, Huntemann, Niklas, Öztürk, Menekse, Schroeter, Christina B., Ruck, Tobias, Meuth, Sven G., Pawlitzki, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Clinical Trial Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464162/
https://www.ncbi.nlm.nih.gov/pubmed/37612774
http://dx.doi.org/10.1186/s42466-023-00267-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464162/
https://www.ncbi.nlm.nih.gov/pubmed/37612774
http://dx.doi.org/10.1186/s42466-023-00267-3

Ejemplares similares